All Companies
LLY
Eli Lilly & Co.Pharmaceutical Preparations
$1,152.93updated Sep 19, 2026
Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Michael A. RulliR | Aug 7, 2026 | Jan 2, 2026 | Buy | $1,001 - $15,000 | +6.72% |
| Byron DonaldsR | May 13, 2026 | Apr 2, 2026 | Buy | $1,001 - $15,000 | +23.23% |
| Byron DonaldsR | May 13, 2026 | Apr 2, 2026 | Buy | $1,001 - $15,000 | +23.23% |
| David TaylorR | Mar 6, 2026 | Feb 26, 2026 | Buy | $1,001 - $15,000 | +12.81% |
| Markwayne MullinR | Jan 16, 2026 | Dec 29, 2025 | Buy | $15,001 - $50,000 | +6.88% |
| Shelley Moore CapitoR | Nov 4, 2025 | Oct 24, 2025 | Buy | $1,001 - $15,000 | +39.67% |
| John BoozmanR | Sep 12, 2025 | Aug 22, 2025 | Buy | $1,001 - $15,000 | +62.00% |
| John BoozmanR | Sep 12, 2025 | Aug 11, 2025 | Buy | $1,001 - $15,000 | +81.50% |
| David TaylorR | Sep 2, 2025 | Aug 14, 2025 | Buy | $15,001 - $50,000 | +68.45% |
| David TaylorR | Sep 2, 2025 | Aug 14, 2025 | Buy | $1,001 - $15,000 | +68.45% |
| Lisa C. McClainR | Aug 13, 2025 | Jul 10, 2025 | Buy | $1,001 - $15,000 | +45.82% |
| Marjorie Taylor GreeneR | May 19, 2025 | May 14, 2025 | Buy | $1,001 - $15,000 | +61.12% |
| Marjorie Taylor GreeneR | May 6, 2025 | May 5, 2025 | Buy | $1,001 - $15,000 | +40.35% |
| Bruce WestermanR | Apr 16, 2025 | Mar 3, 2025 | Buy | $1,001 - $15,000 | +24.01% |
| Ashley MoodyR | Mar 22, 2025 | Mar 6, 2025 | Buy | $100,001 - $250,000 | +26.31% |
| Marjorie Taylor GreeneR | Jan 27, 2025 | Jan 21, 2025 | Buy | $1,001 - $15,000 | +55.31% |